Sequential Portal Vein Embolization and Percutaneous Radiofrequency Ablation for Future Liver Remnant Growth: A Minimally Invasive Alternative to ALPPS Stage-1 in Treatment of Hepatocellular Carcinoma
Qiang Wang(Artificial Intelligence in Medicine (Canada)), Kuansheng Ma(Army Medical University), Ernesto Sparrelid(Karolinska University Hospital), Torkel B. Brismar(Karolinska University Hospital), Jiayun Jiang(Army Medical University), Yujun Ji(Army Medical University), Changfeng Li(Shanxi Medical University), Leida Zhang(Army Medical University), Shu Chen(Army Medical University), Wei Mu(Beihang University)
Cited by 4
Related Papers
The Genomes of Oryza sativa: A History of Duplications
|PLoS Biology|2005|1k
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
The Role of Imaging in the Detection and Management of COVID-19: A Review
|IEEE Reviews in Biomedical Engineering|2020|420
Checklist for Artificial Intelligence in Medical Imaging (CLAIM): 2024 Update
|Radiology Artificial Intelligence|2024|406
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
|Signal Transduction and Targeted Therapy|2023|295